Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-01-17 @ 4:33 AM
Study NCT ID:
NCT00738959
Status:
COMPLETED
Last Update Posted:
2008-10-29
First Post:
2008-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D0190C00008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Didier Meulien, MD, Medical Science Director, Emerging AD & Cognition
Old Organization:
AstraZeneca R&D, Södertälje, Sweden